Literature DB >> 33871096

Aeson-The Carmat total artificial heart is approved for enrollment in the United States.

Jason J Han.   

Abstract

Aeson, the Carmat Total Artificial Heart has been recently approved by the FDA for beginning enrollment in the United States. This follows their recent attainment of CE marking in 2020.
© 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.

Year:  2021        PMID： 33871096     DOI： 10.1111/aor.13959

Source DB:  PubMed          Journal:  Artif Organs        ISSN： 0160-564X            Impact factor:   3.094


  3 in total

1.  Right ventricular dysfunction is best managed with a total artificial heart.

Authors:  Matthew C Henn; Nahush A Mokadam
Journal:  JTCVS Open       Date:  2021-10-29

2.  Mechanical circulatory support: Technical tips for the implantation of a right ventricular assist device.

Authors:  Evgenij Potapov; Christoph Starck; Volkmar Falk; Jaime-Jürgen Eulert-Grehn
Journal:  JTCVS Open       Date:  2021-10-16

Review 3.  Mechanical circulatory support devices and treatment strategies for right heart failure.

Authors:  Taiyo Kuroda; Chihiro Miyagi; Kiyotaka Fukamachi; Jamshid H Karimov
Journal:  Front Cardiovasc Med       Date:  2022-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.